GSK agrees to pay $3bn in US healthcare fraud case
Ssettlement includes $1bn in criminal fines; $2bn in civil fines in over sale of Paxil, Wellbutrin, Avandia products.
The settlement includes $1 billion in criminal fines and $2 billion in civil fines in connection with the sale of the drug company's Paxil, Wellbutrin and Avandia products.
Deputy US Attorney General James Cole said on Monday that the settlement "is unprecedented in both size and scope."
As part of the settlement, GlaxoSmithKline agreed to strict oversight of its sales force by the US government to prevent the use of kickbacks or other prohibited practices.
MOST READ
Paying iPhone 17 Pro Max's PTA tax just got a lot easier, here’s how
67,000 pilgrims to get refunds by October 31, here’s how much
Gold prices drop sharply in Pakistan following global decline
Ducky Bhai’s wife Aroob Jatoi’s gambling app case takes new turn
SIFC steps in to avert fuel crisis
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ